Piper Sandler on Bristol-Myers Squibb Co. (BMY): 'Milvexian Did Strike Us As High-Risk'
Go back to Piper Sandler on Bristol-Myers Squibb Co. (BMY): 'Milvexian Did Strike Us As High-Risk'| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 54.72 +0.26 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.46 | 52 Week High | $77.12 | |||
| Open | $54.56 | 52 Week Low | $49.03 | |||
| Day High | $55.09 | P/E | 35.53 | |||
| Day Low | $54.31 | EPS | $1.54 | |||
| Volume | 11,540,615 | |||||
